Chimigen® HBV: An Immunotherapy for Chronic Hepatitis B

Time: 4:00 pm
day: Day Two

Details:

• Exploring Chimigen®: Novel Immunotherapy Technology Platform

• Breaking immune tolerance to HBV and restoring anti-HBV T cell immunity

• Attaining durable “functional cure” of hepatitis B by restoring antiviral T cell immunity

Speakers: